GlassScriptPhysician profile
Amber Fox
NPI 1427663152
$2,340.09
in general payments reported to CMS, 2019-2025
17 companies · $999 in 2025
The $999 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.07 · 2022: $115 · 2023: $186 · 2024: $1,015 · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,000 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,999.78 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $785.27 | 2024-2025 | Inspire |
| Harmony Biosciences LLC | $467.29 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $332.33 | 2023-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $225.00 | 2025 | Lumryz |
| Axsome Therapeutics, INC. | $132.74 | 2024-2025 | Sunosi |
| Paratek Pharmaceuticals, INC. | $84.18 | 2023 | Nuzyra |
| Melinta Therapeutics, LLC | $65.88 | 2022-2023 | Kimyrsa |
| Abbvie INC. | $43.52 | 2023-2025 | |
| Tactile Systems Technology INC | $40.93 | 2022-2025 | Nimbl, Flexitouch Plus |
| Fisher & Paykel Healthcare INC | $27.99 | 2024 | Fisher & Paykel Healthcare |
| Convatec INC. | $26.02 | 2023 | |
| Advanced Oxygen Therapy INC. | $23.87 | 2022-2023 | Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $23.16 | 2022 | |
| Kci USA, INC. | $19.33 | 2022 | |
| Alkermes, INC. | $17.70 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $17.51 | 2024 | Horizant |
| Genentech USA, INC. | $7.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.